MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Depression in Parkinson’s diseaese: Experience of the neurology department in Mohammed VI third level university hospital

H. El Yachkouri, M. Chraa, N. Kissani (Marrakesh, Morocco)

Meeting: 2019 International Congress

Abstract Number: 367

Keywords: Depression

Session Information

Date: Monday, September 23, 2019

Session Title: Psychiatric Manifestations

Session Time: 1:45pm-3:15pm

Location: Les Muses Terrace, Level 3

Objective: The objectives of this study are to evaluate the frequency of depression in our Parkinson’s disease patients, to describe the relationship of depression to demographic parameters and motor function and specially the stage of the disease.

Background: For decades, Parkinson’s disease (PD) has been considered as a neurodegenerative disorder of pure motor expression.  Currently, it has been shown that an association with non motor symptoms (NMS) is frequent. Depression is the most common NMS in Parkinson’s disease, with a prevalence that varies widely across studies (2.7% to 90%). Despite its frequency, it is often under diagnosed and therefore inadequately treated. The pathophysiology of depression in PD is multifactorial, and may include dysfunction of dopaminergic, serotonergic and noradrenergic systems but is still poorly understood.

Method: The authors report a prospective study on depression, in 115 patients with PD diagnosed over a period of 18 months. The study was conducted in the neurology department of Mohammed VI university hospital of Marrakesh. Patients were administered a detailed questionnaire by a neurologist, and depression was diagnosed using the BDI (Beck depression inventory).

Results: Depression was the most frequent NMS in our patients (75.6%), with a higher prevalence in females (66.7% vs 54.2%). We also found that depression was more frequent in patients with young-onset PD and in the late stage of the disease.

Conclusion: PD is a complex neurodegenerative pathology with a motor and non-motor symptoms, including depression. It is important to consider the frequency of depression in Parkinson’s disease, in order to optimize its diagnosis and treatment.

To cite this abstract in AMA style:

H. El Yachkouri, M. Chraa, N. Kissani. Depression in Parkinson’s diseaese: Experience of the neurology department in Mohammed VI third level university hospital [abstract]. Mov Disord. 2019; 34 (suppl 2). https://www.mdsabstracts.org/abstract/depression-in-parkinsons-diseaese-experience-of-the-neurology-department-in-mohammed-vi-third-level-university-hospital/. Accessed September 5, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/depression-in-parkinsons-diseaese-experience-of-the-neurology-department-in-mohammed-vi-third-level-university-hospital/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • An atypical and interesting feature of Parkinson´s disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • #23812 (not found)
  • Approaching Health Care Shaped by Generational Expectations (The AGE Study): Generational Perspective Related to Time
  • Application of the “5-2-1” Screening Criteria in Advanced Parkinson’s Disease Patients Treated with Levodopa-Carbidopa Intestinal Gel: Interim Analysis from the DUOGLOBE Study
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • An atypical and interesting feature of Parkinson´s disease
  • Patients with Essential Tremor Live Longer than their Relatives
  • DaTscan in clinical evaluation of Multiple System Atrophy
  • Decision-making process for opicapone’s bedtime regimen
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley